![](/img/cover-not-exists.png)
WS7.4 Lumacaftor, an investigational CFTR corrector, in combination with ivacaftor, a CFTR potentiator, in CF patients with the F508del-CFTR mutation: Phase 2 interim analysis
Boyle, M., Bell, S.C., Konstan, M., Colley, S. Mc, Flume, P., Kang, L., Wu, Y., Waltz, D., Patel, N.Volume:
12
Language:
english
Journal:
Journal of Cystic Fibrosis
DOI:
10.1016/S1569-1993(13)60043-0
Date:
June, 2013
File:
PDF, 72 KB
english, 2013